NLRC4 Gene Cold Autoinflammatory Syndrome Type 4 Familial NGS Genetic DNA Test
Understanding NLRC4 Gene Cold Autoinflammatory Syndrome
NLRC4 Gene Cold Autoinflammatory Syndrome Type 4 is a rare hereditary condition characterized by recurrent episodes of systemic inflammation triggered by exposure to cold temperatures. This genetic disorder results from mutations in the NLRC4 gene, which plays a crucial role in regulating the innate immune system’s inflammatory response. When this gene malfunctions, it leads to uncontrolled inflammation throughout the body, causing debilitating symptoms that significantly impact quality of life.
The importance of genetic testing for NLRC4 mutations cannot be overstated. Early and accurate diagnosis enables healthcare providers to implement targeted treatment strategies, prevent disease complications, and provide appropriate genetic counseling for family planning. Without proper diagnosis, patients may undergo unnecessary treatments and experience progressive organ damage from chronic inflammation.
What This Test Measures and Detects
Our advanced NGS Genetic DNA Test specifically analyzes the NLRC4 gene to identify pathogenic variants responsible for familial cold autoinflammatory syndrome type 4. The test examines:
- Complete sequencing of the NLRC4 gene coding regions
- Detection of point mutations, insertions, and deletions
- Identification of known pathogenic variants associated with autoinflammatory syndromes
- Assessment of novel variants with potential clinical significance
Using cutting-edge Next-Generation Sequencing technology, this test provides comprehensive coverage of the NLRC4 gene with exceptional accuracy and sensitivity. The technology enables detection of even rare mutations that might be missed by conventional genetic testing methods.
Who Should Consider This Genetic Test
Clinical Indications and Symptoms
This test is recommended for individuals experiencing:
- Recurrent fever episodes without infectious cause
- Skin rashes or urticaria triggered by cold exposure
- Joint pain and swelling following cold temperature exposure
- Family history of similar autoimmune or inflammatory conditions
- Unexplained systemic inflammation markers in blood tests
- Childhood-onset inflammatory symptoms worsening in cold environments
- Poor response to conventional anti-inflammatory treatments
At-Risk Populations
Individuals with a family history of NLRC4-related disorders should strongly consider genetic testing, as this condition follows an autosomal dominant inheritance pattern. Early testing can facilitate proactive management and prevent disease complications.
Benefits of NLRC4 Genetic Testing
Undergoing genetic testing for NLRC4 mutations provides numerous clinical advantages:
- Accurate Diagnosis: Confirms or rules out NLRC4-related autoinflammatory syndrome
- Personalized Treatment: Enables targeted therapies specific to the underlying genetic cause
- Family Planning Guidance: Provides essential information for genetic counseling and reproductive decisions
- Early Intervention: Facilitates timely treatment to prevent long-term complications
- Symptom Management: Helps develop effective strategies for managing cold-induced symptoms
- Reduced Diagnostic Odyssey: Eliminates years of uncertainty and misdiagnosis
Understanding Your Test Results
Your genetic test results will fall into one of several categories, each with specific clinical implications:
Positive Result
A positive result indicates the presence of a pathogenic NLRC4 gene mutation. This confirms the diagnosis of familial cold autoinflammatory syndrome type 4. Your healthcare provider will develop a comprehensive management plan including:
- Targeted anti-inflammatory medications
- Environmental modifications to minimize cold exposure
- Regular monitoring for disease complications
- Genetic counseling for family members
Negative Result
A negative result means no pathogenic NLRC4 mutations were detected. However, this doesn’t completely rule out an autoinflammatory condition, as other genetic or environmental factors may be involved. Further evaluation may be necessary.
Variant of Uncertain Significance (VUS)
Sometimes, the test identifies genetic changes whose clinical significance is unknown. In such cases, ongoing research and family studies may help clarify the variant’s importance over time.
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Test Details
- Turnaround Time: 3 to 4 Weeks
- Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
- Methodology: Next-Generation Sequencing (NGS) Technology
- Specialty: Dermatology, Genetics, Immunology
Pre-Test Requirements
Before undergoing testing, patients should provide:
- Complete clinical history related to NLRC4 Gene Cold Autoinflammatory Syndrome symptoms
- Participation in a genetic counseling session
- Development of a pedigree chart documenting family members affected by similar conditions
Nationwide Availability
We have diagnostic centers conveniently located throughout the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network ensures accessible genetic testing services for patients across the country.
Take Control of Your Health Today
Don’t let unexplained inflammatory symptoms control your life. Our NLRC4 Genetic DNA Test provides the answers you need for proper diagnosis and effective treatment. With our discounted price of $500 and comprehensive genetic analysis, you can gain valuable insights into your health condition.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation. Our genetic specialists are ready to answer your questions and guide you through the testing process.
Early diagnosis through genetic testing can significantly improve quality of life and prevent long-term complications associated with NLRC4-related autoinflammatory syndromes. Take the first step toward understanding your genetic health and achieving better symptom management.

